ABBVIE FDA Approval NDA 005856

NDA 005856

ABBVIE

FDA Drug Application

Application #005856

Documents

Letter2009-04-29
Letter2012-06-08
Medication Guide2012-06-15
Label2012-06-11

Application Sponsors

NDA 005856ABBVIE

Marketing Status

Discontinued002
Discontinued005
Discontinued009

Application Products

002SOLUTION;ORAL200MG/5ML0TRIDIONETRIMETHADIONE
005CAPSULE;ORAL300MG0TRIDIONETRIMETHADIONE
009TABLET;ORAL150MG1TRIDIONETRIMETHADIONE

FDA Submissions

UNKNOWN; ORIG1AP1946-01-25UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1975-07-31
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1979-06-07
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1978-10-06
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1979-10-24
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1981-09-22
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1982-02-11
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1983-10-28
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1997-07-22
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2002-12-10
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2002-09-26
LABELING; LabelingSUPPL20AP2009-04-23901 REQUIRED
LABELING; LabelingSUPPL21AP2012-06-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2016-06-07

Submissions Property Types

SUPPL5Null0
SUPPL8Null0
SUPPL9Null0
SUPPL12Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL21Null15
SUPPL23Null0

CDER Filings

ABBVIE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 5856
            [companyName] => ABBVIE
            [docInserts] => ["Medication Guide","http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM308402.pdf"]
            [products] => [{"drugName":"TRIDIONE","activeIngredients":"TRIMETHADIONE","strength":"200MG\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"TRIDIONE","activeIngredients":"TRIMETHADIONE","strength":"300MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"TRIDIONE","activeIngredients":"TRIMETHADIONE","strength":"150MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"06\/06\/2012","submission":"SUPPL-21","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/005856s021lbl.pdf\"}]","notes":""},{"actionDate":"06\/06\/2012","submission":"SUPPL-21","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/005856s021lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"TRIDIONE","submission":"TRIMETHADIONE","actionType":"200MG\/5ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"TRIDIONE","submission":"TRIMETHADIONE","actionType":"300MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"TRIDIONE","submission":"TRIMETHADIONE","actionType":"150MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2012-06-06
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.